{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T21:45:04Z","timestamp":1780091104101,"version":"3.54.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81272885"],"award-info":[{"award-number":["81272885"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81172476"],"award-info":[{"award-number":["81172476"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81472427"],"award-info":[{"award-number":["81472427"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81402134"],"award-info":[{"award-number":["81402134"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81001154"],"award-info":[{"award-number":["81001154"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cancerletters.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.canlet.2015.02.028","type":"journal-article","created":{"date-parts":[[2015,2,16]],"date-time":"2015-02-16T17:48:44Z","timestamp":1424108924000},"page":"269-279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Mutant p53 (p53-R248Q) functions as an oncogene in promoting endometrial cancer by up-regulating REG\u03b3"],"prefix":"10.1016","volume":"360","author":[{"given":"Huihui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feizhou","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyun","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binya","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2015.02.028_bib0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J. Clin"},{"key":"10.1016\/j.canlet.2015.02.028_bib0015","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJM199608293350907","article-title":"Endometrial carcinoma","volume":"335","author":"Rose","year":"1996","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.canlet.2015.02.028_bib0020","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/annonc\/mdl417","article-title":"Chemotherapy for advanced, recurrent or metastatic endometrial cancer: a systematic review of Cochrane collaboration","volume":"18","author":"Humber","year":"2007","journal-title":"Ann. Oncol"},{"key":"10.1016\/j.canlet.2015.02.028_bib0025","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/j.1471-0528.2007.01332.x","article-title":"Survival and recurrent disease after postoperative radiotherapy for early endometrial cancer: systematic review and meta-analysis","volume":"114","author":"Johnson","year":"2007","journal-title":"BJOG"},{"key":"10.1016\/j.canlet.2015.02.028_bib0030","first-page":"6788","article-title":"Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome","volume":"60","author":"Sigal","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2015.02.028_bib0035","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/ng0593-42","article-title":"Gain of function mutations in p53","volume":"4","author":"Dittmer","year":"1993","journal-title":"Nat. Genet"},{"key":"10.1016\/j.canlet.2015.02.028_bib0040","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1126\/science.1905840","article-title":"p53 mutations in human cancers","volume":"253","author":"Hollstein","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.canlet.2015.02.028_bib0045","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<814::AID-CNCR12>3.0.CO;2-U","article-title":"The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways","volume":"88","author":"Lax","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2015.02.028_bib0050","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/modpathol.3880062","article-title":"Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature","volume":"13","author":"Kounelis","year":"2000","journal-title":"Mod. Pathol"},{"key":"10.1016\/j.canlet.2015.02.028_bib0055","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0046-8177(03)00124-2","article-title":"Immunohistochemical expression of cyclins, cyclin-dependent kinases, tumor-suppressor gene products, Ki-67, and sex steroid receptors in endometrial carcinoma: positive staining for cyclin A as a poor prognostic indicator","volume":"34","author":"Shih","year":"2003","journal-title":"Hum. Pathol"},{"key":"10.1016\/j.canlet.2015.02.028_bib0060","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrclinonc.2010.216","article-title":"Emerging therapeutic targets in endometrial cancer","volume":"8","author":"Dedes","year":"2011","journal-title":"Nat. Rev. Clin. Oncol"},{"key":"10.1016\/j.canlet.2015.02.028_bib0065","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.cdp.2003.09.005","article-title":"Molecular and histopathologic predictors of distant failure in endometrial cancer","volume":"27","author":"Mariani","year":"2003","journal-title":"Cancer Detect. Prev"},{"key":"10.1016\/j.canlet.2015.02.028_bib0070","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/dc.21837","article-title":"Expression of immunoreactivity of nuclear findings by p53 and cyclin a in endometrial cytology: comparison with endometrial glandular and stromal breakdown and endometrioid adenocarcinoma grade 1","volume":"41","author":"Norimatsu","year":"2013","journal-title":"Diagn. Cytopathol"},{"key":"10.1016\/j.canlet.2015.02.028_bib0075","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1101\/gad.190678.112","article-title":"Mutant p53: one name, many proteins","volume":"26","author":"Freed-Pastor","year":"2012","journal-title":"Genes Dev"},{"key":"10.1016\/j.canlet.2015.02.028_bib0080","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/cdd.2013.17","article-title":"Two hot spot mutant p53 mouse models display differential gain of function in tumorigenesis","volume":"20","author":"Hanel","year":"2013","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.canlet.2015.02.028_bib0085","doi-asserted-by":"crossref","first-page":"e1108","DOI":"10.1038\/cddis.2014.75","article-title":"Unequal prognostic potentials of p53 gain-of-function mutations in human cancers associate with drug-metabolizing activity","volume":"5","author":"Xu","year":"2014","journal-title":"Cell Death Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.canlet.2015.02.028_bib0090","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/S0020-7292(06)60031-3","article-title":"Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of treatment in gynecological cancer","volume":"95","author":"Creasman","year":"2006","journal-title":"Int. J. Gynaecol. Obstet"},{"key":"10.1016\/j.canlet.2015.02.028_bib0095","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cell.2011.03.020","article-title":"Genetic interactions in cancer progression and treatment","volume":"145","author":"Ashworth","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2015.02.028_bib0100","first-page":"6316","article-title":"The proteasome as a target for cancer therapy","volume":"9","author":"Voorhees","year":"2003","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.canlet.2015.02.028_bib0105","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1200\/JCO.2005.11.030","article-title":"Proteasome inhibition as a novel therapeutic target in human cancer","volume":"23","author":"Rajkumar","year":"2005","journal-title":"J. Clin. Oncol"},{"key":"10.1016\/j.canlet.2015.02.028_bib0110","doi-asserted-by":"crossref","first-page":"10515","DOI":"10.1016\/S0021-9258(19)50047-3","article-title":"Identification, purification, and characterization of a protein activator (PA28) of the 20 S proteasome (macropain)","volume":"267","author":"Ma","year":"1992","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.canlet.2015.02.028_bib0115","doi-asserted-by":"crossref","first-page":"22369","DOI":"10.1016\/S0021-9258(18)41681-X","article-title":"Purification of an 11 S regulator of the multicatalytic protease","volume":"267","author":"Dubiel","year":"1992","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.canlet.2015.02.028_bib0120","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cell.2005.11.037","article-title":"The SRC-3\/AIB1 coactivator is degraded in a ubiquitin- and ATP-independent manner by the REGgamma proteasome","volume":"124","author":"Li","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2015.02.028_bib0125","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.molcel.2007.05.022","article-title":"Ubiquitin-independent degradation of cell-cycle inhibitors by the REGgamma proteasome","volume":"26","author":"Chen","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2015.02.028_bib0130","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.molcel.2007.05.028","article-title":"Ubiquitin- and ATP-independent proteolytic turnover of p21 by the REGgamma-proteasome pathway","volume":"26","author":"Li","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2015.02.028_bib0135","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1210\/jc.2002-021413","article-title":"Abnormally high expression of proteasome activator-gamma in thyroid neoplasm","volume":"88","author":"Okamura","year":"2003","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.canlet.2015.02.028_bib0140","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1074\/mcp.M600118-MCP200","article-title":"Identification of PSME3 as a novel serum tumor marker for colorectal cancer by combining two-dimensional polyacrylamide gel electrophoresis with a strictly mass spectrometry-based approach for data analysis","volume":"5","author":"Roessler","year":"2006","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.canlet.2015.02.028_bib0145","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s12032-010-9546-8","article-title":"REG gamma: a potential marker in breast cancer and effect on cell cycle and proliferation of breast cancer cell","volume":"28","author":"Wang","year":"2011","journal-title":"Med. Oncol"},{"key":"10.1016\/j.canlet.2015.02.028_bib0150","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.7314\/APJCP.2012.13.6.2699","article-title":"Expression of proteasome activator REGgamma in human laryngeal carcinoma and associations with tumor suppressor proteins","volume":"13","author":"Li","year":"2012","journal-title":"Asian Pac. J. Cancer Prev"},{"key":"10.1016\/j.canlet.2015.02.028_bib0155","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1471-2407-12-75","article-title":"REGgamma is associated with multiple oncogenic pathways in human cancers","volume":"12","author":"He","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2015.02.028_bib0160","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/CAD.0b013e3282f24031","article-title":"Antioxidants block proteasome inhibitor function in endometrial carcinoma cells","volume":"19","author":"Llobet","year":"2008","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.canlet.2015.02.028_bib0165","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1038\/ncomms3667","article-title":"Differential regulation of the REGgamma-proteasome pathway by p53\/TGF-beta signalling and mutant p53 in cancer cells","volume":"4","author":"Ali","year":"2013","journal-title":"Nat. Commun"},{"key":"10.1016\/j.canlet.2015.02.028_bib0170","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijgo.2009.02.010","article-title":"Revised FIGO staging for carcinoma of the endometrium","volume":"105","author":"Creasman","year":"2009","journal-title":"Int. J. Gynaecol. Obstet"},{"key":"10.1016\/j.canlet.2015.02.028_bib0175","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1476-4598-12-155","article-title":"A TrkB-STAT3-miR-204-5p regulatory circuitry controls proliferation and invasion of endometrial carcinoma cells","volume":"12","author":"Bao","year":"2013","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2015.02.028_bib0180","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s12032-013-0484-0","article-title":"miR-130b is an EMT-related microRNA that targets DICER1 for aggression in endometrial cancer","volume":"30","author":"Li","year":"2013","journal-title":"Med. Oncol"},{"key":"10.1016\/j.canlet.2015.02.028_bib0185","first-page":"6506","article-title":"Analysis of the p53 gene in human uterine carcinoma cell lines","volume":"51","author":"Yaginuma","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2015.02.028_bib0190","first-page":"278","article-title":"Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer","volume":"6","author":"Ramondetta","year":"2000","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.canlet.2015.02.028_bib0195","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2220\/biomedres.31.401","article-title":"Mutant p53 R248Q but not R248W enhances in vitro invasiveness of human lung cancer NCI-H1299 cells","volume":"31","author":"Yoshikawa","year":"2010","journal-title":"Biomed. Res"},{"key":"10.1016\/j.canlet.2015.02.028_bib0200","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00280-004-0767-4","article-title":"Mutant p53 expression enhances drug resistance in a hepatocellular carcinoma cell line","volume":"53","author":"Chan","year":"2004","journal-title":"Cancer Chemother. Pharmacol"},{"key":"10.1016\/j.canlet.2015.02.028_bib0205","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1038\/onc.2012.334","article-title":"Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis","volume":"32","author":"Dong","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2015.02.028_bib0210","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/humu.22514","article-title":"TP53 mutants in the Tower of Babel of cancer progression","volume":"35","author":"Bisio","year":"2014","journal-title":"Hum. Mutat"},{"key":"10.1016\/j.canlet.2015.02.028_bib0215","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/path.2784","article-title":"The role of mutant p53 in human cancer","volume":"223","author":"Goh","year":"2011","journal-title":"J. Pathol"},{"key":"10.1016\/j.canlet.2015.02.028_bib0220","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1476-4598-8-103","article-title":"Elevated expression of p53 gain-of-function mutation R175H in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR\/PI3K\/AKT pathway","volume":"8","author":"Dong","year":"2009","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2015.02.028_bib0225","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.cell.2007.09.007","article-title":"Non-oncogene addiction and the stress phenotype of cancer cells","volume":"130","author":"Solimini","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2015.02.028_bib0230","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/cbin.10139","article-title":"Bortezomib induces apoptosis of endometrial cancer cells through microRNA-17-5p by targeting p21","volume":"37","author":"Shen","year":"2013","journal-title":"Cell Biol. Int"},{"key":"10.1016\/j.canlet.2015.02.028_bib0235","doi-asserted-by":"crossref","first-page":"22118","DOI":"10.1074\/jbc.M601350200","article-title":"Proteasome inhibitors induce death but activate NF-kappaB on endometrial carcinoma cell lines and primary culture explants","volume":"281","author":"Dolcet","year":"2006","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.canlet.2015.02.028_bib0240","doi-asserted-by":"crossref","first-page":"504","DOI":"10.4161\/cc.7.4.5355","article-title":"REGgamma proteasome activator is involved in the maintenance of chromosomal stability","volume":"7","author":"Zannini","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.canlet.2015.02.028_bib0245","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1101\/gad.1214604","article-title":"SUMO and ubiquitin in the nucleus: different functions, similar mechanisms?","volume":"18","author":"Gill","year":"2004","journal-title":"Genes Dev"},{"key":"10.1016\/j.canlet.2015.02.028_bib0250","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/emboj.2008.25","article-title":"Proteasome activator PA28 gamma regulates p53 by enhancing its MDM2-mediated degradation","volume":"27","author":"Zhang","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2015.02.028_bib0255","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.bbrc.2009.02.098","article-title":"Regulation of the stability of cell surface E-cadherin by the proteasome","volume":"381","author":"Saitoh","year":"2009","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1016\/j.canlet.2015.02.028_bib0260","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1038\/onc.2009.214","article-title":"Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP induction","volume":"28","author":"Baritaki","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2015.02.028_bib0265","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10735-008-9208-8","article-title":"Immunohistochemical detection of p53 protein in basal cell skin cancer after microwave-assisted antigen retrieval","volume":"40","author":"Evke","year":"2009","journal-title":"J. Mol. Histol"},{"key":"10.1016\/j.canlet.2015.02.028_bib0270","first-page":"231","article-title":"Mutational analysis of p53 in human tumors: immunocytochemistry","volume":"234","author":"Slade","year":"2003","journal-title":"Methods Mol. Biol"},{"key":"10.1016\/j.canlet.2015.02.028_bib0275","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1038\/ncomms3996","article-title":"Spliced MDM2 isoforms promote mutant p53 accumulation and gain-of-function in tumorigenesis","volume":"4","author":"Zheng","year":"2013","journal-title":"Nat. Commun"},{"key":"10.1016\/j.canlet.2015.02.028_bib0280","doi-asserted-by":"crossref","first-page":"e51426","DOI":"10.1371\/journal.pone.0051426","article-title":"Molecular mechanism of mutant p53 stabilization: the role of HSP70 and MDM2","volume":"7","author":"Wiech","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2015.02.028_bib0285","doi-asserted-by":"crossref","first-page":"e65671","DOI":"10.1371\/journal.pone.0065671","article-title":"MiR-7 triggers cell cycle arrest at the G1\/S transition by targeting multiple genes including Skp2 and Psme3","volume":"8","author":"Sanchez","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2015.02.028_bib0290","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/bjc.2013.728","article-title":"PA28gamma emerges as a novel functional target of tumour suppressor microRNA-7 in non-small-cell lung cancer","volume":"110","author":"Xiong","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2015.02.028_bib0295","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.canlet.2014.12.014","article-title":"miR-7-5p suppresses cell proliferation and induces apoptosis of breast cancer cells mainly by targeting REGgamma","volume":"358","author":"Shi","year":"2015","journal-title":"Cancer Lett"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383515001329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383515001329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T20:52:22Z","timestamp":1651265542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383515001329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0304383515001329"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2015.02.028","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mutant p53 (p53-R248Q) functions as an oncogene in promoting endometrial cancer by up-regulating REG\u03b3","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2015.02.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}